文献速递神经肿瘤

体内实时自荧光技术区分胶质瘤、浸润区和正常脑组织

In Vivo Real-Time Discrimination Among Glioma, Infiltration Zone, and Normal Brain Tissue via Autofluorescence Technology.
PubMed 文献 · World Neurosurg · 2018-11-01

研究将C6胶质瘤细胞植入6只大鼠左大脑半球,5天后用光纤针探头测量双半球不同深度的自荧光,并与组织病理学对比。结果显示正常组织、浸润区、肿瘤及对侧半球间差异极显著(P < 0.001),受试者工作特征曲线下面积为0.978,肿瘤勾画的敏感度和特异度分别为93.9%和94.4%。作者认为该探头可能帮助神经外科医生在不损伤正常脑组织的情况下增加切除范围。

要点

  • 光纤针探头可实时测量大鼠脑组织自荧光。
  • 正常组织、浸润区、肿瘤及对侧半球间自荧光差异极显著(P < 0.001)。
  • 肿瘤勾画敏感度93.9%、特异度94.4%,曲线下面积0.978。

核心结论

  • 新设计的体内光纤探头在本研究中能区分肿瘤浸润区与正常脑组织。
  • 作者认为该探头可能帮助神经外科医生在不损伤正常脑组织的情况下增加切除范围,从而可能改善患者生存和生活质量。

研究设计与样本

  • 体内研究:将C6胶质瘤细胞植入6只大鼠左大脑半球以模拟肿瘤发生。
  • 植入5天后,用新设计的光纤嵌入针探头测量双大脑半球不同深度的自荧光,随后处死大鼠取双半球行组织病理学分析。

主要发现

  • 组织病理学与自荧光对应区域比较显示,正常组织、浸润区、肿瘤及对侧大脑半球间差异极显著(P < 0.001)。
  • 受试者工作特征曲线下面积为0.978。
  • 肿瘤勾画的敏感度为93.9%,特异度为94.4%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgery is the first-line therapy for glioblastoma. There is evidence that extent of resection is significantly associated with patient survival. Unfortunately, optimal surgical resection is usually limited because of the difficulty in discriminating tumor-infiltrated region and normal brain tissue. This study aimed to develop a tool to distinguish between infiltration zone and normal tissue in real time during glioma surgery. METHODS: In an in vivo study, C6 glioma cells were implanted into the left cerebral hemispheres of 6 rats to mimic tumorigenesis. A newly designed optical fiber-embedded needle probe was used to measure the autofluorescence of both cerebral hemispheres at various depths 5 days after the implantation. These rats were then sacrificed, and both cerebral hemispheres were removed for histopathologic analysis. RESULTS: Comparative analyses of corresponding areas by histopathology and autofluorescence revealed highly significant (P < 0.001) differences among the normal tissue, infiltration zone, tumors, and the contralateral cerebral hemispheres. The area of the receiver operating characteristic curve was 0.978, and the sensitivity and specificity of tumor delineation were 93.9% and 94.4%, respectively. CONCLUSIONS: The newly designed in vivo fiber-optic probe can distinguish tumor-infiltration zones from normal brain tissue in this in vivo study. Therefore, it may help neurosurgeons to increase extent of resection without damaging normal brain tissue and thus potentially improve the patients' survival and quality of life.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Chang KT, Lin YY, Lin YY, et al. In Vivo Real-Time Discrimination Among Glioma, Infiltration Zone, and Normal Brain Tissue via Autofluorescence Technology. World Neurosurg. 2018. PMID: 30391621. doi:10.1016/j.wneu.2018.10.144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。